Literature DB >> 12901954

Negative regulation of cytokine signaling and inflammatory diseases.

Kyoko Inagaki-Ohara1, Toshikatsu Hanada, Akihiko Yoshimura.   

Abstract

Immune and inflammatory systems are controlled by multiple cytokines, including interleukins and interferons. These cytokines exert their biological functions through Janus tyrosine kinases and signal transducer and activators of transcription (STATs). The cytokine-inducible SH2 proteins (CIS) and suppressors of cytokine signaling (SOCS) are a family of intracellular proteins, several of which have emerged as key physiological regulators of cytokine responses, including those that regulate the inflammatory system. Several recent advances have been made in this field, including treatment of inflammatory diseases by modulating extracellular and intracellular signaling pathways.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12901954     DOI: 10.1016/s1471-4892(03)00070-5

Source DB:  PubMed          Journal:  Curr Opin Pharmacol        ISSN: 1471-4892            Impact factor:   5.547


  10 in total

1.  Lnk constrains myeloproliferative diseases in mice.

Authors:  Alexey Bersenev; Chao Wu; Joanna Balcerek; Jiang Jing; Mondira Kundu; Gerd A Blobel; Kudakwashe R Chikwava; Wei Tong
Journal:  J Clin Invest       Date:  2010-05-10       Impact factor: 14.808

2.  Lnk inhibits erythropoiesis and Epo-dependent JAK2 activation and downstream signaling pathways.

Authors:  Wei Tong; Jing Zhang; Harvey F Lodish
Journal:  Blood       Date:  2005-02-10       Impact factor: 22.113

3.  Open label safety and efficacy pilot to study mitigation of equine recurrent uveitis through topical suppressor of cytokine signaling-1 mimetic peptide.

Authors:  Caryn E Plummer; Timothy Polk; Jatin Sharma; Sanghyo Sarah Bae; Olivia Barr; Amari Jones; Holly Kitchen; Michelle Wilhelmy; K Devin; W Clay Smith; Bryan D Kolaczkowski; Joseph Larkin
Journal:  Sci Rep       Date:  2022-05-03       Impact factor: 4.996

4.  Lnk inhibits Tpo-mpl signaling and Tpo-mediated megakaryocytopoiesis.

Authors:  Wei Tong; Harvey F Lodish
Journal:  J Exp Med       Date:  2004-08-30       Impact factor: 14.307

5.  The role of the inhibitors of interleukin-6 signal transduction SHP2 and SOCS3 for desensitization of interleukin-6 signalling.

Authors:  Patrick Fischer; Ute Lehmann; Radoslaw M Sobota; Jochen Schmitz; Claudia Niemand; Sonja Linnemann; Serge Haan; Iris Behrmann; Akihiko Yoshimura; James A Johnston; Gerhard Müller-Newen; Peter C Heinrich; Fred Schaper
Journal:  Biochem J       Date:  2004-03-01       Impact factor: 3.857

6.  Cholinergic agonists regulate JAK2/STAT3 signaling to suppress endothelial cell activation.

Authors:  Prodyot K Chatterjee; Yousef Al-Abed; Barbara Sherry; Christine N Metz
Journal:  Am J Physiol Cell Physiol       Date:  2009-09-09       Impact factor: 4.249

Review 7.  Nutritional regulation of leptin signaling.

Authors:  Catherine Ribiere; Charles Plut
Journal:  Curr Hypertens Rep       Date:  2005-02       Impact factor: 5.369

Review 8.  CRISPR Gene Editing of Human Primary NK and T Cells for Cancer Immunotherapy.

Authors:  Ezgi Elmas; Noushin Saljoughian; Marcelo de Souza Fernandes Pereira; Brian P Tullius; Kinnari Sorathia; Robin J Nakkula; Dean A Lee; Meisam Naeimi Kararoudi
Journal:  Front Oncol       Date:  2022-04-05       Impact factor: 5.738

9.  Targeting a cytokine checkpoint enhances the fitness of armored cord blood CAR-NK cells.

Authors:  May Daher; Rafet Basar; Elif Gokdemir; Natalia Baran; Nadima Uprety; Ana Karen Nunez Cortes; Mayela Mendt; Lucila Nassif Kerbauy; Pinaki P Banerjee; Mayra Shanley; Nobuhiko Imahashi; Li Li; Francesca Lorraine Wei Inng Lim; Mohsen Fathi; Ali Rezvan; Vakul Mohanty; Yifei Shen; Hila Shaim; Junjun Lu; Gonca Ozcan; Emily Ensley; Mecit Kaplan; Vandana Nandivada; Mustafa Bdiwi; Sunil Acharya; Yuanxin Xi; Xinhai Wan; Duncan Mak; Enli Liu; Xin Ru Jiang; Sonny Ang; Luis Muniz-Feliciano; Ye Li; Jing Wang; Shahram Kordasti; Nedyalko Petrov; Navin Varadarajan; David Marin; Lorenzo Brunetti; Richard J Skinner; Shangrong Lyu; Leiser Silva; Rolf Turk; Mollie S Schubert; Garrett R Rettig; Matthew S McNeill; Gavin Kurgan; Mark A Behlke; Heng Li; Natalie W Fowlkes; Ken Chen; Marina Konopleva; Richard E Champlin; Elizabeth J Shpall; Katayoun Rezvani
Journal:  Blood       Date:  2021-02-04       Impact factor: 25.476

Review 10.  Overcoming tumor resistance mechanisms in CAR-NK cell therapy.

Authors:  Antonio Valeri; Almudena García-Ortiz; Eva Castellano; Laura Córdoba; Elena Maroto-Martín; Jessica Encinas; Alejandra Leivas; Paula Río; Joaquín Martínez-López
Journal:  Front Immunol       Date:  2022-08-03       Impact factor: 8.786

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.